Breast-cancer adjuvant therapy with zoledronic acid.

Source: New England Journal of Medicine

van der Vliet HJ, Verheul HM  | |  

View the original article

Login or register to help identify topics from this page.

This page may contain content contributed by CPNP members or aggregated from other online sources. This content is provided as an unmoderated service to members for civil discussion and collaboration. Any opinions, conclusions, or recommendations are those of the author. If you come across any abuse or violation of the terms of use, please report the abuse.